Document is current
Any future updates will be listed below
-
Authors
Roth, Gael
Artru, Pascal
Bouche, Olivier
Williet, Nicolas
Ghelfi, Julien
Turpin, Anthony
Lievre, Astrid
Blanc, Jean-Frédéric
Evrard, Camille https://orcid.org/0000-0003-3147-1350
Bachet, Jean-Baptiste https://orcid.org/0000-0003-4337-286X
Parent, Pauline
Manceau, Marc
Roustit, Matthieu https://orcid.org/0000-0003-4475-1626
Borowik, Anna https://orcid.org/0000-0003-2207-8311
Granger, Victoire
Durand, Aurélie
d’Engremont, Christelle
Girard, Edouard
Chirica, Mircea
Braissand, Nicolas
Rama, Nicolas https://orcid.org/0000-0003-1614-7755
Modolo, Eugénie https://orcid.org/0009-0008-0853-1689
Hernandez-Vargas, Hector https://orcid.org/0000-0001-6045-2103
Georges, Elise
Scoazec, Jean-Yves https://orcid.org/0000-0003-1604-6823
Cros, Jerome https://orcid.org/0000-0002-4935-3865
Hazard, Sébastien https://orcid.org/0000-0001-5740-1188
Ducarouge, Benjamin https://orcid.org/0000-0002-6701-0508
Decaens, Thomas
Bernet, Agnès https://orcid.org/0000-0002-8260-9711
Mehlen, Patrick https://orcid.org/0000-0003-1743-5417
- License Information
-
More Information
Article History
Received: 20 October 2025
Accepted: 20 March 2026
First Online: 22 April 2026
Competing interests
: G.R. declares honoraria as consultant and research funding from NETRIS Pharma. A. Bernet and P.M. are founders and shareholders of NETRIS Pharma. B.D., E. Georges and S.H. are employees of NETRIS Pharma. The NP137 patent is fully owned by NETRIS Pharma; none of the authors of this study are inventors on this patent. The other authors declare no competing interests.
